Foldax is developing synthetic heart valves with the goal of delivering non-thrombogenic aortic and mitral valves at dramatically lower costs to existing artificial or tissue valves. It operates in the manufacturing sector. The company was incorporated in 2013 and is based in Salt Lake City, Utah.